BeautyFarm Med Announces Global Offering Results, Offer Price of HK$19.32per Share

Beauty Farm Medical and Health Industry Inc. (BeautyFarm Med or Company, HKG: 2373), the largest provider of traditional beauty services in China, today announced...

Novotech Acquires European CRO, Strengthens Global Operations

Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent....

Novotech Acquires US-based Drug Development Consulting Firm, CBR International

Expands Drug Development and FDA Regulatory Expertise Novotech, the leading Asia Pacific-centered biotech CRO today announced the acquisition of CBR International, a global product...

HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in...

HighTide Therapeutics Inc. (HighTide), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, today announced the dosing of...
Avance Clinical

Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program

More than 40 biotech clients are now taking advantage of Avance Clinical's GlobalReady program which delivers streamlined clinical development from early phase in Australia...

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to...

Prenetics has completed the majority stake acquisition of ACT Genomics to spearhead its entry into to the US$80+ billion global precision oncology market ...

China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC...

China Biotech Services Holdings Limited (the Group; HKG: 8037) has announced that its subsidiary, Asia Molecular Diagnostics Laboratory (AMDL), has been nominated as the...

HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and...

Global biopharmaceutical company focusing on metabolic and digestive diseases Proceeds to fund clinical and business development HighTide Therapeutics Inc. (HighTide), a globally integrated clinical-stage...

Beauty Farm Medical and Health Industry Inc. Announces Proposed Listing on the Main Board...

Beauty Farm Medical and Health Industry Inc. (Beauty Farm or Company, HKG: 2373), the largest provider of traditional beauty services in China, today announces...

Shares of Major Global Medical Device Manufacturer OrbusNeich Medical Group Commence Trading on the...

Shares of OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"), a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary...

Novotech is Gold Sponsor at Biotech Showcase 2023

Novotech, the Asia Pacific centered biotech specialist CRO is proud to be Gold Sponsor at Biotech Showcase 2023. Novotech CEO Dr. John Moller and...

SinoMab Awarded the “Most Valuable Pharmaceutical and Medical Company” in the Selection of the...

SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG: 3681), a Hong Kong-based biopharmaceutical company dedicated to the research,...

Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in...

Prenetics will be acquiring a majority stake in ACT Genomics Holdings Company Limited ("ACT") for an upfront consideration consisting of 19.9 million shares...

Olympus Named to Dow Jones Sustainability World Index for Two Consecutive Years

Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, announced that it has been selected for...

Data Shows 50% of New Trials Have Sites in Asia Pacific

Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication by GlobalData and Novotech found almost 50% of new trials...

Preventing Strokes and Heart Attacks Doesn’t Have to Come with the Risk of Life-threatening...

Verseon is delighted to announce that the European Journal of Medicinal Chemistry has published a paper (www.sciencedirect.com/science/article/abs/pii/S0223523422007577) describing the company's groundbreaking research that led to...

EC Healthcare wins “Best in Healthcare Sector” at IR Magazine’s Greater China Awards 2022

EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital medical group in Hong...

Major Global Medical Device Manufacturer OrbusNeich Medical Group Announces Details of Proposed Listing on...

Global Offering of 54,633,000 Shares at HK$8.80 Per Offer Share OrbusNeich Medical Group Holdings Limited (OrbusNeich or the Group), a major global medical device...

Polymer protection for vaccines and drugs

A biocompatible polymer could help deliver vaccines and drugs with reduced risk of the rare dangerous adverse reaction called anaphylaxis. Researchers at the National...

Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing

Recently, Zhongke Guosheng (Hangzhou) Technology Co., Ltd (hereinafter referred to as GS Biotech) officially announced the completion of its nearly CNY100 million pre-A round...